Form 8-K - Current report:
SEC Accession No. 0001213900-25-037654
Filing Date
2025-04-30
Accepted
2025-04-30 16:30:26
Documents
15
Period of Report
2025-04-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0239740-8k_abvcbio.htm   iXBRL 8-K 36008
2 FORM OF VOTING RIGHTS PROXY AGREEMENT ea023974001ex4-2_abvcbio.htm EX-4.2 14699
3 FORM OF PURCHASE AGREEMENT ea023974001ex10-1_abvcbio.htm EX-10.1 43106
  Complete submission text file 0001213900-25-037654.txt   285148

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE abvc-20250430.xsd EX-101.SCH 3020
5 XBRL LABEL FILE abvc-20250430_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE abvc-20250430_pre.xml EX-101.PRE 22362
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0239740-8k_abvcbio_htm.xml XML 3844
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 25895934
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)